CONTINUUS secures an additional contract for a top-selling generic medication

CONTINUUS Pharmaceuticals expanded its pipeline by securing a contract with a major pharmaceutical client. CONTINUUS will implement its innovative ICM technology platform for a top-selling generic pharmaceutical.  “This represents a great opportunity for generic pharmaceutical companies. Implementing ICM will allow our clients to significantly reduce their cost structure, while improving the quality of their products,” said Chief Business Officer, Bayan Takizawa.